Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BLIZOMIT 10 MG/ML + 5 MG/ML COLIRIO EN SUSPENSIÓN - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/BLIZOMIT 10 MG/ML + 5 MG/ML COLIRIO EN SUSPENSIÓN

Approved

STANDARD

BLIZOMIT 10 MG/ML + 5 MG/ML COLIRIO EN SUSPENSIÓN

Pharmathen S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 9, 2024
Approval ID: 371abdf7ae362df5
Company: Pharmathen S.A.
Type: Standard

Approval Details

Approval Id: 371abdf7ae362df5
Drug Cima Aemps Name: BLIZOMIT 10 MG/ML + 5 MG/ML COLIRIO EN SUSPENSIÓN
Register Number: 89314
Holder Company Name: Pharmathen S.A.
Marketing Company Name: Pharmathen S.A.
Holder Company Detail Path: /organization/pharmathen-s-a
Marketing Company Detail Path: /organization/pharmathen-s-a
Authorization Date: 2024-02-09
Dosage Form: COLIRIO EN SUSPENSIÓN
Dose: 10 mg/ml + 5 mg/ml
Route Of Administration: VÍA OFTÁLMICA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Pharmathen S.A.
Company Detail Path: /organization/pharmathen-s-a

Company Information

Pharmaceutical Company Name: PHARMATHEN S.A.
Country Name: Greece
City Name: pallini,sterea ellada and evoia,country_gr
Address: 6 Dervenakion

Active Ingredients

BRINZOLAMIDA

10 mg/ml

TIMOLOL MALEATO

6,830 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 9, 2024

Approval ID

371abdf7ae362df5

Type

Standard

Back to CIMA-AEMPS Approvals